The George Institute
Type 2 diabetes drug a ‘game changer’
A relatively new drug has been found to greatly reduce risk of cardiovascular and kidney disease – though it comes with risks of its own Canagliflozin (Invokana) is a SGLT2 …
Women at higher risk of chronic lung disease
More women are dying from COPD than breast and lung cancer combined, according to a new report The report, co-authored by Professor Christine Jenkins from The George Institute for Global …
Women overlooked for CVD checks in general practice
With men more likely than women to have their cardiovascular disease risk factors measured by their GP, can pharmacists help bridge the divide? Research from The George Institute for Global …
Inclement weather not to blame for aches and pains
Changes in the weather are not connected with back pain or osteoarthritis symptoms, Australian researchers have concluded A study comparing weather patterns with pain symptoms has shown no association between …